1. Home
  2. BUR vs SANA Comparison

BUR vs SANA Comparison

Compare BUR & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burford Capital Limited

BUR

Burford Capital Limited

N/A

Current Price

$3.62

Market Cap

814.7M

Sector

Finance

ML Signal

N/A

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

N/A

Current Price

$2.01

Market Cap

688.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BUR
SANA
Founded
2009
2018
Country
Guernsey
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
814.7M
688.5M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
BUR
SANA
Price
$3.62
$2.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
★ $8.49
$8.43
AVG Volume (30 Days)
★ 2.7M
2.6M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 3.61%
N/A
EPS Growth
N/A
★ 17.24
EPS
N/A
★ N/A
Revenue
★ $413,360,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.86
$2.00
52 Week High
$10.10
$5.49

Technical Indicators

Market Signals
Indicator
BUR
SANA
Relative Strength Index (RSI) 49.91 32.21
Support Level $3.58 N/A
Resistance Level $4.50 $3.41
Average True Range (ATR) 0.22 0.19
MACD 0.01 -0.02
Stochastic Oscillator 34.04 15.96

Price Performance

Historical Comparison
BUR
SANA

About BUR Burford Capital Limited

Burford Capital Ltd provides capital against the underlying value of litigation and legal assets, known as legal finance, serving the legal industry with financial products and services. Its business is funding clients engaged in ongoing legal disputes to pay legal fees and monetize the expected future value of disputes, focusing on large, complex matters. The company has two reportable segments: Principal Finance, which earns maximum revenue and allocates capital to legal finance assets from its balance sheet and through interests in private funds managed by the company, and Asset Management and Other Services, which manages legal finance assets for third-party investors and provides other services to the legal industry.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Share on Social Networks: